In an online article dated August 22, 2012, James Childs and Jonathan Kipp provided their thoughts on the downward trend in venture capital funding in the life sciences sector. Industry analysts largely expect the downward trend to continue. Childs is Chair of the Emerging Growth Companies Team and Co-Chair of the Life Sciences Industry Team. Kipp is Vice-Chair of the Emerging Growth Companies Team. Both attorneys practice in the firm’s Birmingham office.